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Abstract
Background: Duchenne muscular dystrophy (DMD) is caused by deficient expression of the cytoskeletal protein, dystrophin.
One third of DMD patients also have mental retardation (MR), likely due to mutations preventing expression of dystrophin
and other brain products of the DMD gene expressed from distinct internal promoters. Loss of Dp71, the major DMD-gene
product in brain, is thought to contribute to the severity of MR; however, the specific function of Dp71 is poorly understood.
Methodology/Principal Findings: Complementary approaches were used to explore the role of Dp71 in neuronal function
and identify mechanisms by which Dp71 loss may impair neuronal and cognitive functions. Besides the normal expression
of Dp71 in a subpopulation of astrocytes, we found that a pool of Dp71 colocalizes with synaptic proteins in cultured
neurons and is expressed in synaptic subcellular fractions in adult brains. We report that Dp71-associated protein complexes
interact with specialized modular scaffolds of proteins that cluster glutamate receptors and organize signaling in
postsynaptic densities. We then undertook the first functional examination of the brain and cognitive alterations in the
Dp71-null mice. We found that these mice display abnormal synapse organization and maturation in vitro, altered synapse
density in the adult brain, enhanced glutamatergic transmission and reduced synaptic plasticity in CA1 hippocampus. Dp71-
null mice show selective behavioral disturbances characterized by reduced exploratory and novelty-seeking behavior, mild
retention deficits in inhibitory avoidance, and impairments in spatial learning and memory.
Conclusions/Significance: Results suggest that Dp71 expression in neurons play a regulatory role in glutamatergic synapse
organization and function, which provides a new mechanism by which inactivation of Dp71 in association with that of other
DMD-gene products may lead to increased severity of MR.
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Introduction
Mental retardation (MR) is a clinical feature in a third of
patients suffering from Duchenne muscular dystrophy (DMD), an
X-linked genetic disease caused by mutations in the dystrophin
gene [1]. The etiology of MR in DMD is complex and likely relies
on cumulative effects of inactivation of dystrophin and other
DMD-gene products expressed from distinct internal promoters
(Dp260, Dp140, Dp116, Dp71) [2]. Full-length dystrophin
(Dp427) is derived from three independent promoters that regulate
its spatio-temporal expression in muscles, brain structures and cell
types. Its loss in all DMD patients leads to muscle degeneration. At
least two shorter non-muscle products, Dp140 and Dp71, that in
common with dystrophin harbor the cystein-rich and carboxy-
terminus domains, are also expressed in brain [1] and might be
involved in MR [3]. As Dp71 is the most abundant dystrophin-
gene product in adult brain [4,5] and as DMD patients with
mutations located in Dp71 genomic region display severe MR,
Dp71 loss-of-function, mostly due to translation-terminating
mutations, has emerged as a major contributing factor [2,6].
PLoS ONE | www.plosone.org 1 August 2009 | Volume 4 | Issue 8 | e6574Dp71 is expressed around brain blood vessels, most likely in
perivascular astrocyte endfeet [7], and is detected in cultured
astrocytes [8] and glial Mu ¨ller cells in retina [9], suggesting a role
for Dp71 in blood-brain barrier function. However, Dp71 mRNA
has also been detected in olfactory bulb and hippocampal neurons
[10], and the protein shows expression in cultured neurons [8] and
in postsynaptic densities in vivo [11]. Yet, studies of mouse lines
lacking Dp427 or all dystrophins only showed mild cognitive
impairments and failed to unveil the specific contribution of Dp71
to neuronal function and to the genesis of MR [12–14].
Many X-linked developmental disorders associated with MR
are related to proteins involved in signaling pathways that regulate
cytoskeleton organization at excitatory synapses [15]. Here, to
explore the specific function of Dp71, we examined its expression
in neurons in vivo and in vitro, and characterized its localization in
excitatory synaptic compartments. Because Dp71, as Dp427, is a
key component of dystrophin-associated protein complexes
(DAPC) formed by transmembrane (dystroglycans) and cytoplas-
mic (syntrophins, dystrobrevins) proteins that link the extracellular
matrix to the actin cytoskeleton, and because DAPC may regulate
signaling pathways involved in structural organization of special-
ized membrane-contact zones, in particular clustering of mem-
brane receptors or ion channels [16], we characterized the Dp71-
DAPC in brain and its interactions with postsynaptic proteins.
Dp71-null mice [17] enabled us to examine for the first time the
effects of selective Dp71-DAPC disruption on synapses organiza-
tion in cultured neurons and on neurotransmission, synaptic
plasticity, synapse distribution and ultrastructure in CA1 hippo-
campal area in the adult brain. Finally, we performed the first
behavioral characterization of Dp71-null mice.
Results
Regional, Cellular and Subcellular Expression of Dp71
Expression in Brain
First, replacement of the Dp71 first and unique exon by the b-
gal reporter gene in Dp71-null mice (KO) was used to estimate
Dp71-promoter activity by b-gal-enzyme histochemistry (X-gal
staining) on brain sections. We found that the Dp71 promoter
drives high and widespread expression of the transgenic b-gal gene
in both cortical and subcortical brain structures, including
hippocampal subfields (Figure 1A). This confirms previous studies
of Dp71 mRNA distribution in hippocampal formation [10,18],
and extends the putative expression of Dp71 to pyramidal neurons
of CA1.
We then analyzed the expression of the Dp71 protein, first by
immunoblotting protein extracts from adult rat and mouse brains.
Using polyclonal H4 and monoclonal DYS2 antibodies, both
directed against the carboxy-terminus domain common to all
dystrophin-gene products, we detected the major short dystrophin-
gene product of 71 kDa, Dp71, in the two main hippocampal sub-
regions, the CA1 area and dentate gyrus (DG) (Fig. 1B)
Transcripts encoding Dp71 are known to be alternatively spliced
for exon 71–74 and/or 78 to generate multiple protein products in
various tissues, which bear (Dp71d) or lack (Dp71f) specific
protein-binding regions [19]. To determine whether these splice
variants are expressed in hippocampus, we examined Dp71d
expression with H4 and DYS2 that only react with Dp71 isoforms
bearing exon 78, and Dp71f expression with the 5F3 monoclonal
antibody [20,21] that specifically recognizes variants lacking exon
78 (Figure S1, for Dp71 isoforms and antibody epitopes). As
expected, all antibodies detected the 71 kDa product in WT mice
(Figure 1C), indicating that Dp71d and Dp71f, the two major
forms of Dp71 products resulting from alternative splice events are
normally expressed in hippocampus. No expression was observed
in hippocampus from KO mice, indicating that both Dp71d and
Dp71f are lacking in this Dp71-null model.
We also explored expression of Dp71 using immunofluores-
cence on sections from mouse and rat hippocampus (Figure S2). A
strong immunoreactive signal was present along the walls of blood
vessels and in some astrocyte processes (Figure S2, A), which likely
reflects the major expression of Dp71 in perivascular astrocyte
end-feet [7]. However, both H4 and DYS2 antibodies confirmed
Dp71 neuronal expression in both CA1-3 and dentate gyrus in
WT and dystrophin-deficient mdx mice, but not in Dp71-null mice
(Figure S2, B and C1-3), which is consistent with the distribution
of Dp71 mRNA [10] and the X-gal staining described above.
Punctate immunoreactivity corresponding to synaptic expression
of Dp71 could not be clearly demonstrated on brain sections.
Western blotting of subcellular fractions of adult mouse cortex
and hippocampus, validated by anti-synaptophysin and anti-PSD-
95 antibodies as markers of the pre- and postsynaptic structures,
was used to further detail Dp71 expression in synaptic compart-
ments. The 71 kDa product (Dp71) was detected in total
homogenate (H) and in most of the collected fractions (Figure
S3), and it was clearly expressed in postsynaptic density fractions
(PSD1, PSD2) (Figure 1D). The PSD2 fraction was selectively
associated with expression of the postsynaptic marker, PSD-95,
but not synaptophysin, confirming the presence of Dp71 in the
postsynaptic densities in the adult brain.
Dp71 is Expressed in Excitatory Synapses of Cultured
Neurons
To probe Dp71 expression in synapses of pyramidal cells and
examine its putative role in synapse organization and maturation,
we used immunofluorescence in primary cultured cells from mouse
cortex and hippocampus. After two days in vitro, both H4 and 5F3
antibodies revealed immunoreactivity in the soma and along
neurites in neurons from WT mice (Figure S4 A–B). H4 staining,
characterized by a fine continuous, tiny and diffuse labeling
(Figure 2 A1–A3), was still present in neurons from KO mice
(Figure S4 C–D) and therefore did not reflect the sole expression of
Dp71. In contrast, the 5F3 antibody detected specifically Dp71, as
a discontinuous staining in neuritic processes of cultured
pyramidal neurons from WT (Figure S4, A vs C), but not from
KO mice. This discontinuous but strong staining revealed by 5F3
at varicosities and growth cones (Figure 2 A2, A3) was confirmed
after 21 days of differentiation, when cultured cells show extensive
sprouting of neuritic processes and acquisition of neuronal and
synaptic phenotypes. At this stage, Dp71 had a synaptic pattern of
expression, with immunoreactivity showing discontinuous granu-
lar or clustered structures along dendrites (Figure 2 B1–B3).
Neuronal subpopulation expressing Dp71 was characterized by
double-staining using presynaptic markers of mature excitatory
(Type-1 vesicular glutamate transporter, VGLUT1) or inhibitory
synapses (GAD-65/67). Neurons intensely labeled with GAD-65/
67, likely corresponding to inhibitory neurons, did not express 5F3
immunoreactivity (Figure 2 C1–C3), in contrast to VGLUT1-
positive excitatory neurons that clearly showed staining for Dp71f
(Figure 2 C4–C6). As 2464% of VGLUT1 clusters co-localized
with Dp71 clusters, whereas only 763% of GAD-65/67 clusters
were Dp71-positive, Dp71f isoforms thus appear comparatively
more expressed in excitatory synapses.
In control neurons co-stained for Dp71 and specific synaptic
markers, we found clusters of Dp71 closely in apposition to, and
sometimes co-localized with both VGLUT1 (Figure 2C) and
Shank (Figure 2D), another major post-synaptic density scaffolding
protein interacting with glutamate receptors. Co-localization was
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VGLUT1-positive clusters, suggesting a main localization of Dp71
in postsynaptic compartments. The percent of synapses (defined by
co-localized VGLUT1 and PSD-95 clusters) positive for Dp71 was
4864.25% and 5764.6% of Dp71 clusters were located at
synapses (n=9 control neurons), suggesting that a significant pool
of Dp71 clusters is located at mature excitatory synapses in
neurons of control mice.
The Dp71-DAPC Interacts with Synaptic Proteins
To identify Dp71-associated proteins (DAPs) [11], we carried
out immunoprecipitation (IP) experiments from rat hippocampal
extracts using DYS2 antibody. We found that a1 and a2
dystrobrevins, a and c1-syntrophins, b-dystroglycan and actin
co-immunoprecipitate with Dp71 (Figure 3A). These results were
confirmed by reciprocal IP using a monoclonal antibody directed
against a-dystrobrevins. Here, Dp71 was the only dystrophin-gene
product detected in the bound fraction probed with DYS2,
suggesting that the other dystrophins did not take part in this
specific complex.
Components of the DAPC were still expressed in brains of
Dp71-null mice (Figure 3B). However, b-dystroglycan expression
was drastically reduced in KO mice (,0.5% of WT). Expression of
a-syntrophins was also reduced (,58% of WT), while c1-
syntrophin was overexpressed by more than 200%. In contrast,
no difference was observed in the expression of a-dystrobrevins,
suggesting that Dp71 is not required for membrane targeting of
these DAPs.
Next we found that key neuronal and synaptic proteins can be
co-immunoprecipitated with Dp71. These include AMPA gluta-
mate receptor (AMPAr) subunits GluR1–3, the NR2A-B subunits
of the NMDA subtype of glutamate receptors (NMDAr), the
NMDAr-associated adapter protein, PSD-95, and the G-protein-
activated inwardly rectifying potassium channel 1 (GIRK1)
(Figure 3C). Two non-receptor tyrosine kinases involved in neurite
outgrowth, dendritic spine morphogenesis and synaptic plasticity,
the focal adhesion kinase (FAK) and C-Src, also co-immunopre-
cipitated with Dp71. In contrast, phosphatidylinositol-3 kinase
(PI3K) was not detected in the bound fraction, suggesting absence
of nonspecific binding. Other control experiments (not shown),
such as IP with unspecific whole-molecule IgG followed by
detection with the specific primary and secondary antibodies used
in this study, and IP of protein extracts from KO mice using
DYS2, did not reveal co-IP of the synaptic proteins mentioned
above, which strengthens the conclusion of a specific association of
Dp71, but not other dystrophin-gene products, with signaling
proteins in excitatory synapses.
Reciprocal IP using anti-NR2A-B antibody allowed us to detect
Dp71d and Dp71f, thus showing that both isoforms interact with
the scaffold proteins associated with postsynaptic glutamate
receptors in PSDs (Figure 3D). Another IP using anti-PSD-95
antibody revealed that binding of NMDAr, PSD-95, nNOS and
FAK was not affected in brains from KO mice (Figure 3E),
suggesting that Dp71 may be a partner, or modulator, of the core
scaffold of proteins involved in the organization of glutamatergic
synapses, although its congenital loss does not seem to prevent
expression of these protein complexes.
Dp71 Loss Alters Glutamatergic Synapse Maturation
In cultured neurons from Dp71-null mice, changes in the
number of VGLUT1 clusters and large PSD-95 clusters were
observed, suggesting that Dp71 loss may affect the clustering and
distribution of these synaptic proteins. To quantify this, we used
neuronal cell cultures from WT and KO mice triple immuno-
Figure 1. Regional and subcellular expression of Dp71 in brain. A. Hippocampal Dp71 promoter activity in CA1-3 and dentate gyrus (DG)
revealed by X-gal staining in brain section from a Dp71-null mouse. B. Immunoblots showing dystrophin-gene products detected by polyclonal (H4)
and monoclonal (DYS2) antibodies in dissected CA (1) and DG (2) regions of the rat hippocampal formation. Note that in addition to Dp71, the H4
antibody also revealed Dp427, Dp140 and Dp116. Molecular weight markers are indicated on the left. C. Immunoblots of hippocampal extracts from
WT and Dp71-null (KO) mice. Dp71 isoforms bearing exon 78 were detected by H4 and DYS2 antibodies, and those lacking exon 78 by 5F3. The
doublet of bands detected by 5F3 likely reflects presence of glycosylated and non-glycosylated forms of Dp71f [5,21]. D. Detection of Dp71 in the
postsynaptic densities. Protein extracts from subcellular fractions obtained from control mouse brains were probed with the anti-Dp71 (H4) antibody
(top panel) and with the presynaptic and postsynaptic markers synaptophysin (central panel) and PSD-95 (bottom panel), respectively. H: total
homogenate; PSD1/PSD2: isolated PSD fractions (Detailed distribution in subcellular fractions is shown in Fig. S3).
doi:10.1371/journal.pone.0006574.g001
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PLoS ONE | www.plosone.org 3 August 2009 | Volume 4 | Issue 8 | e6574Figure 2. Expression of Dp71 in mouse excitatory neurons in vitro. A and B. Primary cultured neurons labeled with H4 (red) and 5F3 (green)
antibodies after two (A) and 21 days (B) of differentiation. White box indicates selected neuritic segments shown below at higher magnification. Note
continuous staining with H4 contrasting with discontinuous staining of 5F3 in neurites. C. Dp71 product detected with 5F3 (green, C1, C4) in
subpopulations of inhibitory (C1-3) and excitatory (C4-6) neurons characterized by GAD-67 and VGLUT1 immunostaining. Overlays show co-
expression of Dp71 and VGLUT1 (C6), with juxtaposition of the markers and presence of VGLUT1-positive Dp71 clusters (arrowheads), but very few
co-expression with GAD-67 (C3). D. Representative images of control neurons double-labeled with 5F3 (green, D1) and the postsynaptic marker
Shank (red, D2). Overlay (D3) and higher magnification of a selected dendritic segments (D3, bottom) shows juxtaposition of the two markers and the
presence of Shank-positive Dp71 clusters (arrowhead). Scale bars, 10 mm.
doi:10.1371/journal.pone.0006574.g002
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lacking Dp71, the mean area of PSD-95 clusters was larger than in
controls (p,0.001; Figure 4B, arrows in A5), whereas there was
only a slight, non-significant reduction in the number of PSD-95
puncta (p=0.09, NS; Figure 4C). This suggests that each cluster in
Dp71-deficient neurons contains more PSD-95 protein. Using the
same biochemical fractions as in Figure 1D, we compared PSD-95
expression between genotypes by autoradiography (Figure 4D). A
drastic overexpression of PSD-95 was found in KO mice in the
PSD1 (WT: 32326652, KO: 1010261021; p,0.03) and PSD2
fractions (WT: 18176109, KO: 11025.256802.75; p,0.01). The
ratio of PSD-95 mRNA expression in KO vs WT mice was close to
1, as assessed by quantitative RT-PCR on whole-brain extracts
(normalized to that of the housekeeping-gene, cyclophylin),
indicating no quantitative variation of PSD-95 message between
genotypes (not shown). This suggests that Dp71 loss selectively
increases stabilization or local translation of PSD-95 [22]. We also
found overexpression of PSD-93 in the PSD2 fraction (WT:
63066537, KO: 1500362478, p=0.07), whereas expression of
another synaptic protein, synaptophysin, was not altered,
suggesting that the increased amounts of PSD-95/93 were not
due to a general increase in protein expression. In all, these results
suggest major alterations in the expression, organization and/or
localization of PSD proteins in neurons of Dp71-null mice.
Quantification of VGLUT1 clusters revealed a different pattern
of distribution (Figure 4, A2 vs A6), with an increased number of
VGLUT1-positive puncta (p,0.001; Figure 4C) and a decrease in
their size (p,0.001; Figure 4B). We then quantified the
colocalization of PSD-95 clusters with VGLUT1 as an indicator
of the proportion of functional synapses in cultured neurons (e.g.,
[23]), which was estimated 56.4466.8% in neurons from WT
mice. In neurons from Dp71-null mice, however, colocalization
only reached 27.964.48% and the number of clusters double-
stained with VGLUT1 and PSD-95 (Figure 4, A3 and A7) was
significantly reduced (11.7761.39 per 50 mm) compared to WT
mice (32.6262.22) (p,0.0001), which likely reflected a reduced
density of functional synaptic junctions. Although part of PSD-95
expression in Dp71-null mice may correspond to mislocated
Figure 3. Characterization of the brain Dp71-DAPC. A. Immunoprecipitation of Dp71 with DYS2 or of aDB with aDB antibodies in rat whole-
hippocampus extracts. Co-immunoprecipitated proteins were analyzed on western blots. B. Immunoblots of hippocampal extracts from WT and KO
mice using antibodies directed against a-DB, a-syn, c1-syn, b-DG and actin. C. Immunoprecipitation of Dp71 with DYS2 and westernblot analysis of
interacting proteins in rat hippocampus. Co-immunoprecipitated proteins were AMPAr subunits Glu-R1-3, NMDAr subunits NR2A-B, PSD-95, FAK, C-
Src and GIRK1, not PI3K. D. Immunoprecipitation using the NMDAR2A&B antibody in rat hippocampal extracts. The proteins interacting with the
NMDAr complex were PSD-95, GRB2, Dp71f and Dp71d, a-DB and a-syn. E. Immunoprecipitation of the PSD-95 protein from hippocampal extracts of
KO mice; NMDAr, FAK, a-DB, nNOS and c1-syn were pulled down in the bound fraction. a-DB: a-dystrobrevins, a-syn: a-syntrophin, c1-syn: c1-
syntrophin, b-DG: b-dystroglycan. T: Hippocampus total homogenate; B: Bound fraction; U: Unbound fraction. Proteins molecular mass (left) are
indicated on the right.
doi:10.1371/journal.pone.0006574.g003
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62.0765.12% of the abnormally large PSD-95 clusters
(.0.4 mm
2) observed in KO mice were VGLUT1-positive, thus
indicating that accumulation of PSD-95 also largely occurs in
synaptic regions. Triple-labeling for Dp71, VGLUT1 and PSD-95
(Figure 4 A4) revealed that 4864.25% of excitatory synapses were
Dp71-positive in controls, suggesting that at least half of these
synapses would be affected by Dp71 loss.
Dp71 Loss Alters Excitatory Synapse Density and
Morphology in the Adult Brain
To determine possible morphological alteration of excitatory
synapses in Dp71-null mice in vivo, we compared axospinous
asymetric synapse density and morphology in both genotypes
using quantitative electron microscopy (EM). The volume of the
anterodorsal hippocampus calculated from vibratome sections
used for EM was comparable in WT (3.0160.04 mm
3) and KO
mice (2.9660.41 mm
3)( p .0.91, not shown), suggesting no
differential tissue shrinkage between genotypes. A total of 665
synapses in KO (n=4) and 533 synapses in control mice (n=3)
were analyzed in the distal dendritic layer of CA1 anterodorsal
hippocampus (Figure 5). The majority of axospinous asymetric
synapses were non-perforated (92–94%), whereas perforated
synapse subtype (5–7%; sample image in Fig. 5A) and multiple
spine boutons (MSBs) (1–2%) were less represented. The number
of axospinous excitatory synapses was reduced by ,11% in KO
mice compared to controls (Figure 5B; p,0.029). The density of
the non-perforated subtype was also reduced by ,13% (KO:
2.3261.05, WT: 26.7860.43 per 100 mm
2;p ,0.045), whereas
the densities of perforated synapses and of MSBs were not affected
(not shown). The distribution of PSD lengths in non-perforated
synapses was slightly skewed toward the larger sizes in the KO
mice (Figure 5C) (D=0.087, p,0.024, KS test), which suggests
morphological alteration of the postsynaptic active zone in Dp71-
null mice.
Hippocampal Neurotransmission and Synaptic Plasticity
The basic neuronal architecture of the hippocampus appeared
normal in KO mice (Figure S5). Presynaptic fiber volleys (PFVs)
and AMPA/kainate receptor-mediated field excitatory postsynap-
tic potentials (fEPSPs) were recorded in CA1 in hippocampal slices
from WT (40 slices, 10 mice) and KO mice (37 slices, 9 mice).
Whereas comparable PFVs were measured in KO and WT mice
(p.0.5, NS; Figure S6 A), fEPSP slopes were significantly higher
in KO mice (p,0.001; Figure S6 B), resulting in enhanced
coupling between PFV and fEPSPs (Figure 6A), i.e., enhanced
synaptic transmission. When the NMDAr component of glutama-
tergic transmission was isolated (6 slices from 3 mice of each
genotype), no significant group difference was found in PFVs’
slopes (p.0.7, Figure S6 C), but NMDAr-mediated fEPSPs
(Figure S6 D) and PFV-fEPSP coupling (Figure 6B) were again
significantly enhanced in mutant mice (p,0.05). Analyzing PFVs
in the absence of EPSPs (with 10 mM bicuculline, 10 mM DNQX,
and 30 mM APV in bathing medium) showed no difference
between KO (n=6) and WT mice (n=5) (PFV slope: p.0.8; PFV
amplitude: p.0.8, data not shown), which confirms that the
increased neurotransmission in mutants was not due to changes in
afferent fiber density or excitability.
We then examined long-term potentiation (LTP) using two
protocols of high-frequency stimulation (HFS, 2650 Hz,
26100 Hz). Stimulus intensities were adjusted to obtain compa-
rable fEPSP slopes in the two genotypes before the induction of
LTP (WT: 0.10760.01 V.s
21, KO: 0.11060.001 V.s
21,p .0.5).
When induced by two trains at 50 Hz (WT: 12 slices, 6 mice; KO:
8 slices; 5 mice, Figure 6C), the level of LTP was comparable
between genotypes during the first 15 min after HFS, but the
Figure 4. Dp71 loss alters the organization of glutamatergic synapses in vitro. A. Triple-immunofluorescence staining of dendrite
segments from mature cultured neurons of WT (Top) and KO mice (Bottom), using antibodies directed against PSD-95 (green, A1, A5), VGLUT1 (red,
A2, A6), and Dp71 (blue on overlay in A4). Dp71-deficient neurons show abnormally larger PSD-95 clusters on excitatory synapses (arrows in A5), a
scarcity of synapses double-stained for PSD95 and VGLUT1 (A7) compared to controls (A3). Dp71 clusters positive for both PSD95 and VGLUT1 were
present in WT neurons only (arrow in A4). Scale bars, 10 mm. B–C. Quantitative analyses of PSD-95 and VGLUT1 clusters. Histograms show the size of
the clusters (B, puncta area) and the number of clusters per 50-mm dendritic length (C, puncta/50 mm), in WT (white) versus Dp71-null neurons
(black). *p,0.001. D. Immunoblot analysis of PSD95 expression in total homogenate (H) and postsynaptic density fractions (PSD1, PSD2) from WT
and KO mouse brain extracts (n=15 mice per genotype distributed in three independent immunoblots).
doi:10.1371/journal.pone.0006574.g004
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in KO than in WT mice (last 15 min, p,0.04). When LTP was
induced by a stronger HFS (26100 Hz; WT: 11 slices; 6 mice;
KO: 11 slices, 5 mice, Figure 6D), the magnitude of LTP was
significantly reduced in KO mice (128.4061% of baseline)
compared to WT mice (160.1861.04%) during 1 h post-HFS
(p,0.02). Immediately post-tetanus (30 s), fEPSP potentiation was
already significantly smaller in KO (185.08615.88%) than in WT
mice (289.26634.64%) (p,0.02), and remained significantly
reduced for at least 30 min (p,0.01). During the last 10 min of
recording, LTP levels were comparable in KO (125.1662.76%)
and WT mice (143.6861.25%) (p.0.2), indicating that this
stronger HFS protocol induced stable and comparable LTP
maintenance in the two genotypes.
We also analyzed forms of short-term plasticity, paired-pulse
facilitation (PPF) and posttetanic potentiation (PTP). The slopes of
the firstfEPSP wereadjusted to similar levelsin KO (n=5, 14 slices)
andWTmice(n=5,12slices) beforeinductionofPPF(p.0.6). The
PPF ratio was however significantly decreased in slices from KO
compared to WT mice (p,0.02, Fig. 6E), suggesting alteration in
presynaptic mechanisms of glutamate release. PTP was induced by
delivering HFS (26100 Hz) in the presence of 80 mM APV. The
transient PTP, which decayed to baseline within a few minutes in
both KO (8 slices, 5 mice) and WT mice (7 slices, 5 mice), was
statistically comparable between genotypes (Figure S6 E). This
confirmed that LTP in both genotypes is NMDAr-dependent and
suggests that LTP impairment in Dp71-null mice is not due to
reduced presynaptic efficiency.
Finally, we examined LTD induced by LFS (900 pulses at 1 Hz)
in area CA1 in 9 slices from WT (n=5) and 8 slices from KO mice
(n=4). The time course and magnitude of LTD were comparable
between genotypes during 1 h post-LFS (p.0.8; Figure 6F),
suggesting that reduced LTP in KO mice is not due to facilitation
of LTD mechanisms.
Behavioral Analysis of Dp71-Null Mice
Motor Capacities. KO and WT mice showed comparable
fall latencies in the inverted grid test (44.2564.53 s and
41.3864.82 s, respectively) and comparable latencies to grip the
wire in the suspension test (2.5460.43 s and 2.3660.49 s) (p.0.6).
Although KO mice had reduced locomotor activity during the first
10 min of open-field exploration (p,0.05), they displayed fast
habituation and similar baseline locomotion compared to controls
from approximately 15 min until the end of testing (Figure 7A).
KO mice also showed normal avoidance of the center zone of the
arena compared to controls (not shown). Both genotypes showed
comparable locomotor activity in a cross-maze (number of arms
visited; KO: 19.4461.64; WT: 22.0561.73; p.0.3) and similar
rearing frequency in both experiments (not shown). This indicates
that basal motor functions were not affected by the loss of Dp71, in
agreement with the lack of overt muscle histopathology in this
model (not shown) and the absence of Dp71 expression in
differentiated skeletal muscles [17].
Exploration and Emotional Reactivity. The initial
reduction of activity shown by KO mice during forced
exploration of the open-field was confirmed when mice were
repeatedly exposed to the open-field during habituation sessions
preceding object recognition testing (number of squares crossed,
p,0.002; crossings in central area, p,0.05; rearings, p,0.05). A
clear reduction of object exploration was also detected during both
acquisition and retention sessions of this task: Object investigations
were comparable between genotypes on the first acquisition session,
whereas they were significantly reduced in KO mice when exposed
to new sets of objects on successivesessions (Figure 7B). A significant
decrease in the number of contacts with objects (p,0.007) and in
the duration of object exploration (p,0.03) was observed during
both acquisition and retention. In contrast, no reduction of
exploratory behavior was observed when KO mice were exposed
to a novel arena that offered a retreat opportunity into a small
familiar home-box (free-choice exploration, all parameters p.0.5,
not shown). Finally, no difference was found between genotypes in
the plus-maze anxiety test (% entries in open arms: WT:
16.6163.82; KO: 13.1464.94, p.0.2). Thus, KO mice exhibited
reduced exploratory and novelty-seeking behaviors, which could
not be directly attributed to enhanced emotional reactivity.
Learning and Memory. In the object recognition task, the
percent time spent exploring each of the two objects during
acquisition was comparable in WT (49.3 and 50.6961.89%) and
KO mice (50.69 and 49.3162.74%). Following a 10 min, 24 h or
48 h delay, one of the familiar objects was replaced by a novel
object and the time spent exploring the novel object (recognition
index) was measured. No statistical difference was detected between
groups: The recognition index differed significantly from chance in
both WT and KO mice at the 10 min and 24 h delays, but not at
the 48 h delay (Figure 7C), both genotypes showing good and
comparable short and long-term recognition memory, and a
similar rate of forgetting.
Figure 5. Dp71 loss affects density and morphology of
axospinous asymmetric synapses in CA1 hippocampus in vivo.
A. Electron micrograph showing the CA1 neuropil (stratum radiatum)
with typical non-perforated (NP) and perforated (P) subtypes of
excitatory synapses. Scale bar, 1 mm. B. Relative density of axospinous
asymmetric synapses expressed as synapses per 100 mm
2.* p ,0.05. C.
Frequency histogram distributions of the PSD length of sampled CA1
spine synapses in 25 nm bins. Insert shows measures of PSD length in
NP and P synapses, with the total length of a perforated PSD estimated
as the sum of the individual electron-dense traces. Scale bar: 0.5 mm.
doi:10.1371/journal.pone.0006574.g005
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number of different arm choices within every set of 4 arm entries
(WT: 3.2860.04; KO: 3.1960.06; p.0.3) and their performance
was not affected by stereotyped response patterns (% chaining:
WT: 19.9963.65; KO: 24.3765.05, p.0.4), suggesting that
spontaneous alternation is not impaired in KO mice. In contrast,
KO mice showed impaired performance when spatial delayed
alternation was assessed in a T-maze (Figure 7D). Only WT mice
showed significant alternation rates at 6 h and 24 h, suggesting
impaired spatial memory performance at long delays in KO mice.
During spatial learning in the water-maze, acquisition of the
navigation task was clearly impaired in Dp71-null mice, which, in
contrast to WT mice, showed no significant improvement of
performance over training (Figure 7E), as expressed by the latency
(last 4 blocks of trials, genotype effect: p,0.01) and distance swum
(p,0.01) to find the platform. While mice of both genotypes had
Figure 6. Dp71 loss alters synaptic transmission and plasticity in CA1 hippocampal area. KO: Filled symbols; WT: Open symbols. A. Basal
glutamatergic transmission mediated via AMPAr. Sample traces (Top) show examples of AMPAr-mediated fEPSPs in response to single pulses
(stimulation intensity: 300 mA); neurotransmission (bottom) is expressed as AMPAr-mediated fEPSP slopes plotted against presynaptic fiber volley
(PFV) slopes (PFV-fEPSP coupling). B. NMDAr component of glutamatergic transmission. Sample traces of NMDAr-mediated fEPSPs (Top, stimulation
intensity: 500 mA) and NMDAr-mediated PFV-fEPSP coupling (bottom). The fEPSPs were isolated in the presence of bicuculline and DNQX. C–D. Time-
course of LTP induced by HFS (time 0) at 2650 Hz (C) and 26100 Hz (D). Synaptic strength is expressed as percent change of fEPSP slopes from
baseline taken as 100% (dotted line) and plotted against time. Sample traces show averaged fEPSPs recorded in response to constant test stimuli in
stratum radiatum of CA1 area before (a) and 45–60 min after induction (b). E. PPF induced by stimulus pairs (50 ms inter-pulse interval) and
expressed as the ratio of the second over the first fEPSP slopes. *p,0.02.F. Time course of LTD of the fEPSP after low frequency stimulation (900
pulses at 1 Hz). Sample traces show averaged fEPSPs recorded before (a) and 60 min after induction (b) (scale bars: 5 ms, 0.5 mV).
doi:10.1371/journal.pone.0006574.g006
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WT: Open symbols. A. Spontaneous locomotor activity during exploration of an empty open-field (9 KO, 10 WT). The number of squares crossed
along the walls for 50 min is shown by bins of 5 min recorded every 10 min. *p,0.02. B. Object investigations expressed as the number of contacts
made with three different sets of objects used during successive acquisition sessions in the object recognition task (13 KO, 16 WT). *p,0.01. C.
Object-recognition memory performance at retention delays of 10 min, 24 h and 48 h. *significantly different from chance (50%), p,0.05. D. Spatial
alternation in a T-maze. Data are % of mice alternating (14 KO, 24 WT) at retention delays of 1, 6 and 24 h. *significantly different from 50%, p,0.05.
E. Spatial learning in the water-maze (12 KO, 10 WT). Escape latencies (left panel) and distance swum to reach the platform (right panel) monitored
over 7 days (1 block of 4 trials per day). *p,0.05. F. Contextual and cued-fear memory. Graph shows percent freezing (12 KO, 13 WT) before (pre-CS)
and immediately after administration of the unconditioned stimulus (US, footshock) during learning (CS-US), and during retention trials 24 h later in
the same context (context test), or in a new context before (new context) and after presentation of the auditory CS (cue-CS test). G. Inhibitory
avoidance learning (17 Dp71-null, 12 WT). Retention performance at 24 h is expressed as the latency to step into the electrified zone. *p,0.05.
doi:10.1371/journal.pone.0006574.g007
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KO mice displayed higher accelerations during progression
segments (p,0.05) and a high rate of 360u-rotation of the animal’s
body (p,0.0001), suggesting darting or impulsive-like responses
and increased path tortuosity. When training was performed in a
smaller pool with a larger platform and with one more trial per
day (see Materials and Methods S1), conditions that likely reduce
task difficulty, WT mice showed faster learning (Figure S7), but
KO mice were still impaired, showing delayed acquisition of the
task (Escape latency: p,0.05; day 2: p,0.008). In these
conditions, however, their performance progressively improved
and reached similar scores as that of the controls on the last two
training days (p.0.2). The KO mice also displayed slightly longer
latencies during a reversal test (p.0.05, NS), which was
reminiscent of the performance deficit during acquisition.
Associative learning was assessed using three different fear-
conditioning protocols: The hippocampus-dependent contextual
and amygdala-dependent cued-fear conditioning, and inhibitory
avoidance. Retention performance was evaluated 24 h post-
training by measuring freezing to the context alone (context test)
and to the auditory conditioned stimulus (CS, tone) delivered in a
new context (cue-CS test), and by the latency to enter the
electrified zone in inhibitory avoidance. KO and WT mice
expressed comparable freezing behavior during habituation,
acquisition and retention of both contextual and auditory-cued
fear conditioning (Figure 7F). Both groups also displayed
comparable performance during acquisition of inhibitory avoid-
ance learning (not shown), but the latency to enter the electrified
zone was shorter in KO than in WT mice at the 24 h retention
delay (Fig. 7G).
Discussion
In DMD, Dp71 deficiency is associated with MR in a
subpopulation of patients [6] and is thought to contribute to the
severity of MR phenotypes. Dp71 function is however unclear and
complex, as the protein appears to be expressed in both
perivascular astrocyte end-feet and neurons. Here, we further
characterized this complex pattern of expression and show that
Dp71 interacts with specialized modular scaffolds that organize
signaling complexes at glutamatergic synapses. We also found that
Dp71 loss affects synaptic maturation and function, and results in
deficits in selective cognitive functions.
The data provide evidence for an association of Dp71-DAPC
with the multi-protein scaffolds that cluster glutamate receptors and
organize signaling proteins required for synaptic transmission and
plasticity, including NMDAr and AMPAr subunits, and other PDZ-
containingproteins such as PSD-95 and nNOS. This specific Dp71-
DAPC contains the two main splice variants, Dp71d and Dp71f,
along with b-dystroglycan, a- and c1-syntrophins and a-dystro-
brevins. Dp71-DAPC is also associated with key signaling proteins
such as FAK, c-Src and Grb2, proteins known to contribute to
neurite outgrowth, dendritic spine morphogenesis and synaptic
plasticity [24–26]. It has been shown that in the nervous system
DAPC binds nNOS [27], ErbB4 neuregulin receptors [28] and
transmembrane channels [29,30] through the PDZ domain of
syntrophins, whereas the adaptor protein Grb2 mediates FAK/b-
dystroglycan interactions [31]. Future studies will determine
whether such mechanisms can explain how Dp71-DAPC binds to
synaptic proteins. Interestingly, we found that Dp71-DAPC also
interacts with GIRK1 (Kir3.1) potassium channels typically
detected in perisynaptic lipid rafts [32]. This suggests cross-linkage
between organizing molecules of the PSD and lipid rafts and the
possible existence of two distinct pools of Dp71-DAPC in PSD and
in perisynaptic regions. In brains of Dp71-null mice, loss of Dp71
resulted in reduced levels of b-dystroglycan and a-syntrophin. This,
however, did not prevent the formation of NMDAr complexes,
which also maintained stable associations with a-dystrobrevins and
a-syntrophin, suggesting that distinct mechanisms are involved in
postsynaptic membrane targeting of Dp71, DAPs and members of
glutamate-receptor complexes.
Emerging notion conceptualize DAPC as a scaffold for proteins
involved in membrane stabilization and transmembrane signaling
[16]. DAPC stabilizes large clusters of acetylcholine receptors at the
neuromuscular junction in association with utrophin [33] and
modulates GABAA-receptor clustering in association with Dp427 in
central inhibitory synapses [34] without being required for
membrane anchoring of these receptors. Here, we found that
cultured primary neurons from Dp71-null mice have abnormally
large clusters of PSD-95 protein and a reduced number of mature
synapses. Hence, whereas Dp71-DAPC seems dispensable for
postsynaptic targeting of glutamate receptor complexes, it may be a
key modulator of their organized distribution. At the ultrastructural
level in the adult brain, we found that KO mice have a reduced
number of excitatory synapses (,11–13%) with larger cross-
sectional PSD length, which parallels our findings in cultured
neurons and suggests reduced synapse density and altered
morphology of the postsynaptic active zone in Dp71-null mice.
Using the hippocampal slice preparation, we found that both
AMPAr and NMDAr-mediated components of CA1 glutamatergic
transmission were drastically enhanced in KO mice. This was
associated with reduced LTP levels, yet larger magnitude of LTP
could be achieved in KO mice with stronger tetanization protocols,
whereasLTD was not affected. Given the range of proteins found to
interact with Dp71-DAPC, such alterations could be attributed to
severalpre- and postsynaptic mechanisms. A presynaptic hypothesis
involving increased glutamate release is suggested by the overall
increase in neurotransmission and reduced paired-pulse facilitation
observed in KO mice. Moreover, in cultured neurons congenital
loss of Dp71 was associated with an altered distribution of the
presynaptic vesicular transporter VGLUT1. A purely presynaptic
account seems however unlikely as PTP under NMDAr blockade
was comparable between genotypes. On the other hand, the
contribution of postsynaptic mechanisms to enhanced synaptic
transmission in Dp71-KO is suggested by the increased PSD length,
which may correlate with aggregation of receptors and signaling
molecules at the active zone [35–37], and by the abnormal
accumulation of PSD-95 in Dp71-deficient synapses, which could
increase NMDAr gating [38], promote the delivery of AMPAr to
synapses and increase AMPAr currents [39–41]. Such changes
could explain that LTP expression was partially occluded in the
Dp71 mutant mice, as suggested in mice overexpressing PSD-95
[40,41]. At this stage, however, the primary mechanisms linking
Dp71 loss to altered synaptic function remain uncertain. The
observed synaptic alterations indicate that the congenital loss of
Dp71 significantly impinges synapse organization and maturation,
but does not imply that Dp71 takes part actively to experience-
driven synaptic plasticity in the adult brain. Moreover, other factors
related to Dp71 function in other cell types might also contribute to
thephenotype:TheDp71-DAPCappearstoendorseamajorrolein
the clustering of aquaporin (AQP4) channels in perivascular
astrocytes [7] and its disruption may alter the blood-brain barrier
and water and K+homeostasis, which could indirectly affect
neuronal function [42].
The diversity of mechanisms presumably modified as a
consequence of Dp71 loss underscores the complex cellular and
subcellular distribution of Dp71 in brain. The finding that a pool
of Dp71 may act as a regulator of glutamatergic synapse
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into identifying some of the complex functional pathways
underlying MR in DMD. Special interest should focus on factors
and signals that coordinate the interplay between the pre- and
postsynaptic compartments during synapse morphogenesis and
plasticity, which appear involved in several types of mental
disorders [15]. The behavioral characterization of Dp71-null mice
revealed selective disturbances characterized by reduced explor-
atory behavior, slight retention deficits in inhibitory avoidance,
and impaired spatial learning and memory. In Dp71-null mice,
exploration deficits may partly relate to emotional reactivity,
neglect and/or withdrawal from novelty-seeking behavior; disor-
ders that have been associated with enhanced glutamatergic
transmission [43]. Such deficiencies that may compromise the
patients’ autonomy and social rehabilitation have not as yet been
systematically assessed in DMD (but see [44,45]). Impaired
navigation in the water maze and spatial alternation in the T-
maze suggest an alteration in hippocampus-dependent encoding
and/or consolidation of spatial information, in line with the
synaptic and neurophysiological alterations observed in Dp71-null
mice in this structure. However, the ability of Dp71-null mice to
reach a normal level of performance in the navigation task when
task difficulty is reduced, the mild deficit in inhibitory avoidance
and unaffected retention performance in object recognition and
contextual fear conditioning suggest that certain hippocampal
functions are preserved. Although the Dp71-null mouse constitutes
a unique model to explore the specific contribution of congenital
Dp71 loss in brain, it is important to note that the genesis of MR in
DMD likely encompass cumulative inactivation of Dp427, Dp71
and Dp140 [2,3]. The function of Dp140 in brain is at present
unknown [1]. Loss of Dp427 in mdx mice alters GABAA-receptor
clustering [34], which has been associated with abnormal
enhancement of hippocampal LTP [13,46], reorganization of
inhibitory synapses and morphological alterations of hippocampal
excitatory-synapse subtypes [47], and behavioral impairments
mainly characterized by mild memory retention deficits [13,48].
Here we show that Dp71, in addition to its potential role in the
control of the blood-brain barrier in relation to its expression in
perivascular astrocytes [7], plays a role in glutamatergic synapse
organization and function and that its loss also results in cognitive
impairments. The present results suggest stronger learning
impairments in Dp71-null mice than in mdx mice, which supports
the hypothesis that Dp71 loss has a major role in the genesis of
cognitive deficits in DMD. However, the two models display
distinct synaptic and behavioral alterations and it would thus be
interesting in future studies to examine the consequences of
mutations preventing the expression of both proteins. This could
be tentatively addressed with the mdx
3CV mutant mouse that lacks
all dystrophin-gene products, but the few studies to date show that
this model does not replicate the behavioral and neurophysiolog-
ical alterations reported in mdx [12,14] and Dp71-null mice. The
possibility that residual expression or compensatory mechanisms
may attenuate the loss of dystrophins in this model has not been
resolved. The generation of new mouse models with brain-specific
mutations and combined loss-of-function of several dystrophin-
gene products will thus be an important step to determine the
respective involvement of GABAergic and glutamatergic functions
in the neural basis of MR in DMD.
Materials and Methods
Ethics Statement
Animal studies complied with the European Communities
Council Directive (CEE 86/609) for animal care and experimen-
tation and were conducted following the guidelines of the animal
facilities in Orsay (France) approved by the national direction of
veterinary services (Direction des Services Ve ´te ´rinaires, DSV-
France, agreement # B91-429 for the rats and B91-471-104 for
the mice).
Animals
Male Wistar rats, dystrophin-deficient mdx mice and Dp71-null
mice(KO) and their control WT littermates (.3 mo old) were used.
Rats were purchased from Charles River (France); mdx mice and
their controls of the C57BL/10ScSn strain were originally
purchased from Jackson Laboratories (USA) and Harlan (France),
respectively, and then bred in the mouse transgenic facility in Orsay
(France) as described [13]; Dp71-null and littermate controls were
produced in the animal facility at Weizmann Institute (Israel).
Animals werekept under a 12-h light-dark cycle (light on: 7.00 a.m.)
with food and water ad libitum. Generation of Dp71-null mice by
homologous recombination has been described previously [17].
Briefly, most of the first and unique exon and a small part of the first
intron of Dp71 have been replaced by the promoter-less gene
encoding a b-gal-neomycin resistance chimeric protein, which
specifically abolished the expression of Dp71 without interfering
with the expression of other DMD-gene products. Females
heterozygous for the mutation were backcrossed for at least 9–10
generations to balb/c males to generate the KO and littermate WT
mice. Genotype was determined by PCR analysis of tail DNA.
Functional analyses were conducted blind to the genotype.
Biochemistry
Antibodies. The polyclonal H4 antibody directed against the
C-terminal part of dystrophins and recognizing Dp71, the specific
monoclonal 5F3 antibody directed against the last 31 residues of
Dp71 isoforms lacking exon 78 (Figure S1), and the antibodies
directed against b-dystroglycan, a- and c1-syntrophins were all
generated by D. Mornet and characterized in detail. The
monoclonal DYS2 antibody (Novocastra Laboratories,
Newcastle, U.K.) is directed against the C-terminal part of
dystrophins, in the same region of the protein as H4. All antibodies
used and sources are described in Table S1. Fluorescein- or
Cyanine 3-conjugated goat anti-rabbit, donkey anti-rabbit and
goat anti-mouse secondary antibodies were from Jackson
ImmunoResearch (West Grove, PA, USA).
Western blot analyses. Brains were removed immediately
after decapitation and whole hippocampi were dissected out. In
some experiments the dentate gyrus and CA1-3 hippocampal
subfield were dissected and analyzed as separate samples. Mouse
dissected brain structures were homogenized with a polytron (30 s,
4uC, full speed) in 5 volumes (wt/vol) of extraction buffer. Protein
concentration was evaluated by nanodrop. Equivalent amounts of
protein were resolved on 10% (rat) or 8% (mouse) SDS-PAGE and
electrotransferred to a nitrocellulose membrane.
For the subcellular and PSD fractionation, five mouse brains
were used in a procedure adapted from Huttner et al. [49]. On the
last step of the protocol, the PSD fractions PSD1 and PSD2 were
resuspended as described elsewhere [50,51] (see Materials and
Methods S1 and Figure S3 for a detailed description).
For immunoprecipitation assays, one mg-protein of rat
hippocampus was homogenized in RIPA 1 buffer (50 mM Tris-
HCl pH 8, 150 mM NaCl, 1% Triton X-100, 0.1% SDS, 1%
sodium deoxycholate, and 2.5 mM EDTA) containing protease
inhibitors and incubated overnight at 4uC with appropriate
antibody. Protein-antibody complexes were mixed with Protein
A/G Plus Agarose (Santa Cruz Biotechnology, USA) and
incubated overnight at 4uC. After extensive washing with buffer
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100, 0.02% SDS and 0.2% sodium deoxycholate) the resin
containing the protein-antibody complexes was suspended in
sample buffer (1/3 of initial volume), boiled and analyzed by
western blot (bound fraction). The buffer of the crude extract used
for immunoprecipitation was diluted 1:10 and analyzed in parallel
(unbound fraction).
Cell culture. Cortex from individual mice at embryonic day
15.5 (E15.5) were dissected, dissociated by trypsin treatment and
mechanical trituration, and plated onto polylysine-coated glass
coverslips (14 mm in diameter) (SIGMA-Aldrich) at a density of
,5000 neurons/cm
2. Cultures were maintained in neurobasal
medium complemented with B27 and glutamate (Invitrogen) as
described elsewhere [52].
Immunocytochemistry. Cultured cells were fixed with 100%
methanol at 220uC for 10 min, permeabilized with 0.1% triton X-
100, blocked in PBS plus 3% BSA, and then incubated with
appropriate primary and secondary antibodies. For triple-staining
assays, Zenon labeling technology (Molecular probes,Invitrogen) was
applied to enable the use of two monoclonal antibodies on mouse
tissues. For quantification of immunostained puncta, images were
taken with a 40X oil-objective, automatically threshold and analyzed
with the ImageJ software (NIH, USA, http://rsb.info.nih.gov/ij/). A
total of 35 primary dendrites from 7 neurons were analyzed for each
genotype. For each dendrite, a 50-mm segment was analyzed
(250 mm per neuron). Each experiment was repeated at least twice
with independent neuronal cultures. Neurons from each genotype
were analyzed using identical imaging conditions to quantify Dp71
co-localization with presynaptic (VGLUT1) and postsynaptic
(SHANK) markers of mature excitatory synapses and with a
presynaptic marker of inhibitory synapses (GAD-65/67). A synapse
was defined by juxtaposition of the pre- and postsynaptic markers.
Immunohistochemistry. Fresh frozen brains were processed
as described [53]. Sections were fixed for 3 min in acetone/
methanol (1:1) at 220uC, stained for 24 h at 4uC with primary
antibody and then incubated 45 min with secondary antibodies. In
some experiments the tissue was fixed by transcardiac perfusion
with 4% paraformaldehyde in 0.1M-phosphate buffer (pH 7.4).
Controls were prepared by omitting the primary antibody; in these
controls, no specific staining could be detected.
X-gal staining. Beta-galactosidase enzyme histochemistry
was performed on both fresh-frozen and formalin-fixed brains
from Dp71-null mice. Sections were washed in 0.1M PBS, stained
for 1 h at 40uC with X-gal (Promega France), dehydrated and
then cleared in Xylene. Dimethyl Formamide (0.4%), MgCl2 (1M),
potassium ferrocyanide (5%) and ferricyanide (5%) were added to
the staining buffer.
Electron microscopy
Brain tissue was processed as previously described [47] (see
Materials and Methods S1). Ultrathin sections (70-nm thick) were
visualized at614000 using a Philips EM208 transmission electron
microscope (Philips Electron Optics, Eindhoven, NL) and
photographed with a CCD AMT digital camera (Hamamatsu,
Japan). Synapses were examined in the distal stratum radiatum
(,150 mm from the CA1 pyramidal cell bodies). Axospinous
symmetric (excitatory) synapses were identified by a thick PSD,
synaptic cleft and presynaptic component with synaptic vesicles
[54]. Those with one or more perforations in the PSD were
classified as perforated and those showing a continuous PSD as
non-perforated (Figure 5A). Single presynaptic terminals contact-
ing more than one postsynaptic spine were defined as multiple
spine boutons (MSBs). The relative density of asymmetric synapses
(synapses per mm
2) and the cross-sectional length of their PSDs
were estimated from 15 counting frames per animal (total sampled
neuropil area: 663.33 mm
2). When the PSD was perforated, the
sum of the individual trace lengths was considered for PSD length
(Figure 5C, insert) [36].
Electrophysiology
Acute hippocampal slices from mice (3–4 mo) were used as
previously described [13]. Extracellular synaptic responses were
recorded in CA1 stratum radiatum to monitor PFVs and fEPSPs
evoked by electrical stimulation of the Schaffer collateral/commis-
sural fibers at 0.1 Hz. Input/output curves were constructed by
measuringtheslopesoffEPSPsmediatedbyAMPArandNMDArat
different stimulus intensities (100–500 mA; 60 ms duration, averages
of 3 responses). NMDAr-mediated responses were isolated in the
presence of the GABAA receptor antagonist, bicuculline (10 mM),
and the AMPA/kainate receptor antagonist 6,7-Dinitroquinoxaline-
2,3-dione (DNQX, 10 mM). Addition of D-APV (30 mM) was used
to analyze PFVs in the absence of EPSPs. PPF was induced by
stimulation with pairs of pulses with a 50-ms interstimulus interval
and quantified as the ratio of the second over the first fEPSP slopes.
To investigate LTP, the initial slope of 3 averaged fEPSPs was
measured for 15 min (baseline) and tetanic stimulation consisted of
two trains, 20 s apart, of HFS of either 50 Hz or 100 Hz (duration:
1 s at test intensity). LTD was induced by low-frequency stimulation
(900 pulses at 1 Hz). Testing with single pulses was resumed for
60 min after induction of synaptic plasticity.
Behavioral testing
Subjects. Eighty-six male mice on a main balb/c background
(40 KO and 46 WT littermates), aged 3 to 8 month, were used.
Because mice with inbred balb/c background are considered poor
learners in spatial tasks, outcrosses between female balb/c-
heterozygous for Dp71 and C57BL/6 male mice were
undertaken to obtain CB6F1 hybrids tested in the water maze.
The behavioral paradigms have been conducted as described
[13,48,55,56] with few adaptations. Detailed protocols are
provided as supporting information in Materials and Methods S1.
Statistical analyses
Data are reported as means6SEM. They were analyzed using
ANOVA with genotype as the between-subject factor, comple-
mented by a within-subject factor analysis for time or place
dependence of effects (Statview 5.0). One set of data, the latencies
recorded in inhibitory avoidance, did not pass the normality and
equal-variance tests (SigmaStat 2.0, SPSS Inc.) and was therefore
analyzed with non-parametric Mann-Whitney U test. In object
recognition, comparison of recognition indexes to chance was
performed using univariate t-tests. In delayed alternation, a chi-
square analysis was used to compare alternation rates to chance.
The distribution of PSD length in the EM study was analyzed with
the Kolmogorov-Smirnov (KS) test.
Supporting Information
Figure S1 Schematic representation of Dp71 isoforms. (A) Dp71
is transcribed from a promoter located between exons 62 and 63 of
the DMD gene; it has a unique N-terminus of seven amino acids
and contains the cysteine-rich and common C-terminal domain of
dystrophins, a region for binding to DAPs complexes. (B) Dp71
alternative spliced transcripts. Dp71d isoform lacks exon 71 and
Dp71f isoform lacks exons 71 and 78 (Marquez et al.,
Neuroscience 118:957–966, 2003). Deletion of exon 78 changes
the reading frame, resulting in the replacement of the last 13
hydrophilic amino acids of dystrophin with 31 new hydrophobic
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PLoS ONE | www.plosone.org 12 August 2009 | Volume 4 | Issue 8 | e6574amino acids in the Dp71 protein. Variants of Dp71 protein with
minor expression in brain have also been described (Austin et al.,
Neuromuscul Disord 10(3):187–93, 2000): Dp71D110m is derived
from Dp71 transcripts deleted for exons 71–74 and contains the
C-terminal sequence of muscle dystrophin, while Dp71D110a
contains the alternative 31-amino acid C-terminal sequence due to
the splicing of exon 78 (Austin et al., J Biol Chem 277:47106–
47113, 2002). The location of the epitopes recognized by
antibodies H4, DYS2 and 5F3 are indicated.
Found at: doi:10.1371/journal.pone.0006574.s001 (1.01 MB TIF)
Figure S2 Immunofluorescence detection of Dp71 in brain
sections. Hippocampal expression of Dp71 isoforms revealed by
H4 on rat brain sections. Representative images show Dp71
expression in (A) walls of blood vessels and perivascular astrocytes
(arrowhead), and (B) in the granule-cell layer (gcl) of dentate gyrus
as incomplete rings of immunoreactivity circling granule cell
bodies and small to large dots around or within cell bodies. C.
Immunolabeling of Dp71 with H4 antibody in the gcl and walls of
blood vessels (arrowheads) in WT (C1), mdx (C2) and Dp71-null
mice (C3).
Found at: doi:10.1371/journal.pone.0006574.s002 (2.61 MB TIF)
Figure S3 Fractionation study. A. Schematic representation of
the fractionation protocol (detailed description in Materials and
Methods S1). B. Protein extracts from subcellular fractions
obtained from control mouse brains probed with the anti-Dp71
(H4) antibody (top panel). Bottom panels show expression of the
presynaptic and postsynaptic markers synaptophysin and PSD-95,
respectively. Fractions as follows: H, total homogenate; S1, cell
soma; P1, dense nuclei-associated membrane; S2, supernatant, P2:
crude synaptosomal membrane, S3, cytosolic; P3, light membrane
compartment; LS1, soluble; LP1, synaptosomal membrane; LP2,
synaptic-vesicle enriched; SPM, synaptic plasma membrane;
PSD1/PSD2, postsynaptic density fractions.
Found at: doi:10.1371/journal.pone.0006574.s003 (1.84 MB TIF)
Figure S4 Expression of Dp71 in cultured neurons of control
(WT) and Dp71-null (KO) mice. Immunofluorescence assays were
performed using the H4 antibody (red) that binds all dystrophin-
gene products and the 5F3 antibody (green) directed against Dp71
isoforms lacking exon 78. Representative images of cultured
neurons from WT (A, B) and KO mice (C, D). Both antibodies
labeled neurites and perinuclear regions of control neurons. H4
immunolabeling was present in both control and Dp71-deficient
cells, reflecting its binding to several dystrophin-gene products. In
contrast, 5F3 antibody labeled neurites of control neurons, but not
that of Dp71-deficient neurons. This staining pattern confirms that
5F3 detects specifically Dp71 isoforms lacking exon 78 and
expressed in neurites. 5F3 also revealed a basal discontinuous
granular labeling in the Golgi complex in both control and Dp71-
deficient neurons, which may reflect binding to another dystro-
phin-like protein in the perinuclear region (Cha ´vez et al., Biochem
Biophys Res Commun 274:275–280, 2000). Nuclei stained with
DAPI (blue).
Found at: doi:10.1371/journal.pone.0006574.s004 (0.66 MB TIF)
Figure S5 Gross hippocampal anatomy is normal in Dp71-null
mice. Formalin-fixed brain sections of WT and KO mice were
immunostained with various cell markers: NeuN antibody was
used to stain neuronal nuclei in CA1-4 and DG regions. Tuj-1
antibody immunostained pyramidal neurons and basal dentrites in
CA1. The anti-parvalbumin antibody was used to reveal
parvalbumin-containing interneurons.
Found at: doi:10.1371/journal.pone.0006574.s005 (3.70 MB TIF)
Figure S6 Basal neurotransmission and PTP in Dp71-null and
WT mice. (A–B) Basal glutamatergic transmission mediated
through AMPAr: (A) presynaptic fibre volley (PFV) slopes plotted
against intensity; (B) AMPAr-mediated fEPSP slopes plotted
against intensity. (C–D). NMDAr component of glutamatergic
transmission: (C) PFV and (D) NMDAr-mediated fEPSP against
intensity. WT(open symbols) and KO mice (black symbols). (E)
Time-course of the post-tetanic potentiation (PTP) induced by a
26100 Hz HFS delivered in the presence of the NMDAr
antagonist APV (80 mM). Genotype effect: p.0.37, NS.
Found at: doi:10.1371/journal.pone.0006574.s006 (0.62 MB TIF)
Figure S7 Spatial learning and reversal in the water maze. In
this experiment, the pool diameter was 1.30 m and mice were
submitted to 5 daily trials (Dark symbols, 10 KO, Open symbols,
16 WT). Acquisition was followed by a reversal task (arrow) on day
5. Escape latencies show delayed learning in KO mice during the
first two days (p,0.05), with improved performance by day 3–4
and intact reversal.
Found at: doi:10.1371/journal.pone.0006574.s007 (0.43 MB TIF)
Table S1 Primary antibodies used in this study. *It could be the
immunogen.
Found at: doi:10.1371/journal.pone.0006574.s008 (0.05 MB
DOC)
Materials and Methods S1 Supplemental Materials and
Methods.
Found at: doi:10.1371/journal.pone.0006574.s009 (0.04 MB
DOC)
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